These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7734775)

  • 1. [Repertory of T lymphocytes in patients with stage A chronic lymphoid leukemia: revealed by monoclonal expansion of T cells in vivo].
    Farace F; Kremer F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
    Bull Cancer; 1994 Oct; 81(10):897-9. PubMed ID: 7734775
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell signaling and costimulatory molecules in B-chronic lymphocytic leukemia (B-CLL): an increased abnormal expression by advancing stage.
    Rossmann ED; Jeddi-Tehrani M; Osterborg A; Mellstedt H
    Leukemia; 2003 Nov; 17(11):2252-4. PubMed ID: 14576733
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia.
    Chiorazzi N; Rai KR; Ferrarini M
    N Engl J Med; 2005 Feb; 352(8):804-15. PubMed ID: 15728813
    [No Abstract]   [Full Text] [Related]  

  • 5. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
    Milosević D; Marinković M; Colović M; Jelić S
    Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional changes in chronic lymphocytic leukemia.
    Răileanu-Moţoiu I; Dumitrescu A
    Rom J Intern Med; 1993; 31(2):99-108. PubMed ID: 8268837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cells in CLL: victims or villains?
    Pepper CJ
    Leuk Res; 2009 Jun; 33(6):752. PubMed ID: 19070899
    [No Abstract]   [Full Text] [Related]  

  • 9. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
    Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
    J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
    Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.
    Farace F; Orlanducci F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
    J Immunol; 1994 Nov; 153(9):4281-90. PubMed ID: 7930628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in T lymphocyte subgroups and their effect in chronic B-lymphoid leukemia].
    Burger T; Molnár L; Schmelzer M; Tóvari E; Szabó A; Paál M; Királyfalvi L
    Orv Hetil; 1988 Oct; 129(41):2189-93. PubMed ID: 3054694
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes in humans express ZAP-70 when activated in vivo.
    Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
    Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.